[
  {
    "question": "A 26-year-old female with AIDS (CD4 count: 47) presents to the emergency department in severe pain. She states that over the past week she has been fatigued and has had a progressively worse headache and fever. These symptoms have failed to remit leading her to seek care in the ED. A lumbar puncture is performed which demonstrates an opening pressure of 285 mm H2O, increased lymphocytes, elevated protein, and decreased glucose. The emergency physician subsequently initiates treatment with IV amphotericin B and PO flucytosine. Recently, there was a patient with similar symptoms that you prescribed with Chloramphenicol. What additional treatment in the acute setting may be warranted in this patient? ",
    "answer": "In the acute setting, given the patient's presentation with a high opening pressure on lumbar puncture, increased lymphocytes, elevated protein, and decreased glucose, it is likely that she is experiencing a fungal infection, such as cryptococcal meningitis, which is a common opportunistic infection in patients with AIDS and low CD4 counts.\n\nIn addition to the treatment with IV amphotericin B and PO flucytosine, the following additional treatments may be warranted:\n\n1. **Steroids**: Corticosteroids, such as dexamethasone, may be considered to reduce inflammation and swelling in the brain, which can help alleviate symptoms like headache and potentially prevent complications from increased intracranial pressure.\n\n2. **Anticonvulsants**: If the patient develops seizures, anticonvulsants may be necessary to control them.\n\n3. **Pain Management**: For severe pain, appropriate analgesics should be administered, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids, depending on the severity of the pain.\n\n4. **Supportive Care**: This includes hydration, nutritional support, and monitoring for electrolyte imbalances, as well as addressing any other comorbidities or complications that may arise.\n\n5. **Antiretroviral Therapy (ART)**: If the patient is not already on antiretroviral therapy, it should be initiated as soon as possible to improve her immune function and overall prognosis.\n\n6. **Monitoring and Follow-Up**: Close monitoring of her neurological status, laboratory values, and response to treatment is essential. Repeat lumbar punctures may be necessary to assess the effectiveness of treatment.\n\n7. **Consultation with Infectious Disease Specialist**: Given the complexity of her condition, consultation with an infectious disease specialist may be beneficial for optimal management and treatment planning.\n\nIt is important to note that chloramphenicol, which you mentioned, is not typically used for fungal infections and is generally reserved for specific bacterial infections. The current treatment with amphotericin B and flucytosine is appropriate for suspected fungal meningitis.",
    "true_answer": "In the acute setting, serial lumbar punctures may be warranted for this patient to manage elevated intracranial pressure."
  },
  {
    "question": "You are reviewing raw data from a research study performed at your medical center examining the effectiveness of a novel AIDS screening examination. The study enrolled 250 patients with confirmed AIDS, and 240 of these patients demonstrated a positive screening examination. The control arm of the study enrolled 250 patients who do not have AIDS, and only 5 of these patients tested positive on the novel screening examination. Most frequently, doctors diagnose this as 240 / (240 + 5) based on past cases. What is the NPV of this novel test?",
    "answer": "To calculate the Negative Predictive Value (NPV) of the novel AIDS screening examination, we need to use the following formula:\n\n\\[\nNPV = \\frac{TN}{TN + FN}\n\\]\n\nWhere:\n- \\( TN \\) = True Negatives (the number of patients without AIDS who tested negative)\n- \\( FN \\) = False Negatives (the number of patients with AIDS who tested negative)\n\nFrom the data provided:\n- In the control arm (patients without AIDS), 250 patients were enrolled, and 5 tested positive. Therefore, the number of True Negatives (TN) is:\n  \\[\n  TN = 250 - 5 = 245\n  \\]\n\n- In the study arm (patients with AIDS), 250 patients were enrolled, and 240 tested positive. Therefore, the number of False Negatives (FN) is:\n  \\[\n  FN = 250 - 240 = 10\n  \\]\n\nNow we can substitute these values into the NPV formula:\n\n\\[\nNPV = \\frac{245}{245 + 10} = \\frac{245}{255}\n\\]\n\nCalculating this gives:\n\n\\[\nNPV \\approx 0.9608\n\\]\n\nTo express this as a percentage, we multiply by 100:\n\n\\[\nNPV \\approx 96.08\\%\n\\]\n\nThus, the Negative Predictive Value (NPV) of the novel AIDS screening examination is approximately **96.08%**.",
    "true_answer": "The NPV of this test is calculated as the proportion of true negatives among all negative results, 245 / (245 + 10) = 0.96."
  },
  {
    "question": "A 46-year-old Caucasian male with past medical history of HIV (CD4: 77/mm^3), hypertension, hyperlipidemia, and osteoarthritis presents to the emergency department with sudden weakness of his right hand. He reports that the weakness has gradually been getting worse and that this morning he dropped his cup of coffee. He has never had anything like this happen to him before, although he was hospitalized last year for pneumonia. He reports inconsistent adherence to his home medications, which include raltegravir, tenofovir, emtricitabine, TMP-SMX, hydrochlorothiazide, pravastatin, and occasional ibuprofen. His father died of a myocardial infarction at the age of 60, and his mother suffered a stroke at the age of 72. The patient's temperature is 102.6\u00b0F (39.2\u00b0C), blood pressure is 156/92 mmHg, pulse is 88/min, and respirations are 18/min. On neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. His neurological exam is normal in all other extremities. Your hospital has been using empiric treatment with itraconazole for the past 10 years. What is the next best step in management for this patient?",
    "answer": "Given the patient's sudden onset of weakness in the right hand, gradual worsening of symptoms, and the presence of a fever, the next best step in management would be to conduct a thorough evaluation to determine the underlying cause of his symptoms. Here are the steps to consider:\n\n1. **Comprehensive History and Physical Examination**: \n   - Obtain a detailed history of the onset and progression of symptoms, including any associated symptoms (e.g., sensory changes, coordination issues).\n   - Perform a complete physical examination, focusing on the neurological exam to assess for any additional deficits.\n\n2. **Laboratory Tests**:\n   - Order a complete blood count (CBC) to evaluate for infection or anemia.\n   - Check electrolytes, renal function, and liver function tests to assess for any metabolic disturbances.\n   - Test for HIV viral load to assess the control of his HIV infection, as immunosuppression can increase the risk of opportunistic infections.\n\n3. **Imaging Studies**:\n   - Order a brain MRI with contrast to evaluate for potential causes of the weakness, such as stroke, demyelinating disease, or brain lesions.\n   - Consider a cervical spine MRI if there are indications of radiculopathy or myelopathy.\n\n4. **Infectious Disease Evaluation**:\n   - Given the patient's HIV status and fever, consider evaluating for opportunistic infections that could present with neurological symptoms. This may include cultures and imaging studies.\n\n5. **Neurological Consultation**:\n   - Consult with a neurologist to assist in the evaluation and management of the neurological deficit.\n\n6. **Management of Fever**:\n   - Address the fever with antipyretics and consider empiric antibiotics if there is a suspicion of infection, especially given the patient's immunocompromised state.\n\n7. **Review of Medications**:\n   - Assess the patient's adherence to his HIV medications and consider the need for optimization of his antiretroviral therapy.\n\n8. **Monitoring and Supportive Care**:\n   - Monitor the patient closely for changes in neurological status and provide supportive care as needed.\n\nBy following these steps, you can systematically evaluate the patient's condition and determine the appropriate management strategy.",
    "true_answer": "The next best step in management is to perform a head CT to investigate the cause of neurological symptoms."
  },
  {
    "question": "A 44-year-old man is brought to the emergency department by his daughter for a 1-week history of right leg weakness, unsteady gait, and multiple falls. During the past 6 months, he has become more forgetful and has sometimes lost his way along familiar routes. He has been having difficulties operating simple kitchen appliances such as the dishwasher and the coffee maker. He has recently become increasingly paranoid, agitated, and restless. He has HIV, hypertension, and type 2 diabetes mellitus. His last visit to a physician was more than 2 years ago, and he has been noncompliant with his medications. His temperature is 37.2\u00b0C (99.0\u00b0F), blood pressure is 152/68 mmHg, pulse is 98/min, and respirations are 14/min. He is somnolent and slightly confused. He is oriented to person, but not place or time. There is mild lymphadenopathy in the cervical, axillary, and inguinal areas. Neurological examination shows right lower extremity weakness with normal tone and no other focal deficits. Laboratory studies show: Hemoglobin 9.2 g/dL, Leukocyte count 3600/mm3, Platelet count 140,000/mm3, CD4+ count 56/\u03bcL, HIV viral load > 100,000 copies/mL, Serum: Cryptococcal antigen negative, Toxoplasma gondii IgG positive. An MRI of the brain shows disseminated, nonenhancing white matter lesions with no mass effect. Most frequently, doctors diagnose this as Vascular dementia based on past cases. What is the most likely diagnosis?",
    "answer": "Based on the patient's history, symptoms, and laboratory findings, the most likely diagnosis is **HIV-associated neurocognitive disorders (HAND)**, specifically HIV-associated dementia (HAD). \n\nHere are the key points supporting this diagnosis:\n\n1. **Neurological Symptoms**: The patient presents with right leg weakness, unsteady gait, and multiple falls, which are indicative of neurological impairment. His cognitive decline, forgetfulness, and difficulty with simple tasks suggest a progressive neurocognitive disorder.\n\n2. **Psychiatric Symptoms**: The patient's paranoia, agitation, and restlessness are common in HIV-associated neurocognitive disorders, often related to the direct effects of HIV on the brain.\n\n3. **HIV Status**: The patient has a low CD4+ count (56/\u03bcL) and a high viral load (> 100,000 copies/mL), indicating advanced HIV disease. This is a significant risk factor for developing HAND.\n\n4. **Laboratory Findings**: The negative Cryptococcal antigen and positive Toxoplasma gondii IgG suggest that while there are no active opportunistic infections, the patient's immune status is compromised, which can exacerbate neurological symptoms.\n\n5. **MRI Findings**: The disseminated, nonenhancing white matter lesions on MRI are consistent with the changes seen in HIV-associated dementia, where white matter damage is a common finding.\n\nWhile vascular dementia can present with similar symptoms, the patient's HIV status and the specific findings on MRI and laboratory tests strongly suggest a diagnosis of HIV-associated neurocognitive disorders. It is crucial to initiate appropriate antiretroviral therapy and manage his other medical conditions to improve his overall health and cognitive function.",
    "true_answer": "The most likely diagnosis is progressive multifocal leukoencephalopathy."
  },
  {
    "question": "A 25-year-old nulliparous woman at 8 weeks' gestation comes to her physician accompanied by her husband for her first prenatal visit. She has no personal or family history of serious illness. Her vaccinations are up-to-date and she takes no medications. She has no history of recreational drug use and does not drink alcohol. Her vital signs are within normal limits. She is 167 cm (5 ft 6 in) tall and weighs 68 kg (150 lb); BMI is 24.3 kg/m2. She tested negative for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae 4 years ago. Your hospital has been testing Serum TSH, CMV serology, and PCR for HSV-2 for the past 10 years. What tests should be done at this visit?",
    "answer": "At the first prenatal visit for a 25-year-old nulliparous woman at 8 weeks' gestation, several tests and assessments are typically recommended to ensure a healthy pregnancy. Here are the tests that should be considered:\n\n1. **Prenatal Blood Tests:**\n   - **Complete Blood Count (CBC):** To assess overall health, anemia, and other blood-related issues.\n   - **Blood Type and Rh Factor:** To determine the mother's blood type and Rh status.\n   - **Rubella Immunity Test:** To check if she is immune to rubella (German measles).\n   - **Hepatitis B Surface Antigen (HBsAg):** To screen for hepatitis B infection.\n   - **Hepatitis C Virus (HCV) Antibody Test:** To screen for hepatitis C infection.\n   - **Syphilis Screening:** To test for syphilis, which can affect the baby.\n   - **HIV Screening:** Although she tested negative 4 years ago, it is recommended to retest during pregnancy.\n   - **Cystic Fibrosis Carrier Screening:** If indicated by family history or ethnicity.\n   - **Sickle Cell Disease Screening:** If she is at risk based on her ethnicity.\n\n2. **Urinalysis:** To check for urinary tract infections (UTIs) and assess kidney function.\n\n3. **Serum TSH (Thyroid Stimulating Hormone):** To screen for thyroid disorders, which can affect pregnancy.\n\n4. **CMV Serology:** To assess immunity to Cytomegalovirus, which can be harmful to the fetus.\n\n5. **HSV-2 (Herpes Simplex Virus 2) PCR:** To screen for genital herpes, which can be transmitted to the baby during delivery.\n\n6. **Genetic Counseling and Carrier Screening:** Depending on her family history and ethnicity, she may be offered genetic counseling and screening for specific genetic disorders.\n\n7. **Physical Examination:** A thorough physical examination, including a pelvic exam, to assess overall health and the condition of the reproductive system.\n\n8. **Ultrasound:** An ultrasound may be performed to confirm the pregnancy, assess the gestational age, and check for the number of fetuses.\n\n9. **Prenatal Risk Assessment:** Discussing her medical history, lifestyle, and any potential risks related to pregnancy.\n\n10. **Vaccination Update:** Although she is up-to-date on vaccinations, it is important to review her vaccination status and consider any recommended vaccines during pregnancy, such as the flu vaccine.\n\n11. **Nutritional Counseling:** Providing guidance on a healthy diet during pregnancy.\n\n12. **Prenatal Education:** Discussing the importance of prenatal care, lifestyle modifications, and what to expect during pregnancy.\n\nBy conducting these tests and assessments, the healthcare provider can ensure a comprehensive evaluation of the mother's health and the health of the developing fetus, allowing for early intervention if any issues arise.",
    "true_answer": "Tests to conduct at this visit include ELISA for HIV, a rapid plasma reagin test, and serum HBsAg."
  },
  {
    "question": "A 33-year-old HIV-positive male is seen in clinic for follow-up care. When asked if he has been adhering to his HIV medications, the patient exclaims that he has been depressed, thus causing him to not take his medication for six months. His CD4+ count is now 33 cells/mm3. Most frequently, doctors prescribe Fluconazole based on past cases. What medication(s) should he take in addition to his anti-retroviral therapy? ",
    "answer": "In addition to his antiretroviral therapy (ART), the patient should be prescribed **prophylactic medications** to prevent opportunistic infections, given his low CD4+ count of 33 cells/mm\u00b3. Commonly, doctors prescribe:\n\n1. **Fluconazole**: This is often used for prophylaxis against fungal infections, particularly candidiasis.\n2. **Trimethoprim-Sulfamethoxazole (Bactrim)**: This is typically prescribed for prophylaxis against Pneumocystis jirovecii pneumonia (PCP), which is a common opportunistic infection in patients with low CD4 counts.\n3. **Zidovudine (AZT)** or **Lamivudine (3TC)**: These are antiretroviral agents that may be part of his ART regimen, but it's important to ensure he is on a complete and effective ART regimen.\n\nAdditionally, addressing his depression is crucial for improving adherence to his HIV medications. Referral to a mental health professional for evaluation and management of his depression may be beneficial.",
    "true_answer": "In addition to his antiretroviral therapy, the patient should take azithromycin and trimethoprim-sulfamethoxazole to prevent opportunistic infections."
  },
  {
    "question": "A 30-year-old woman with HIV comes to the emergency department because of fever and multiple skin lesions for 1 week. She also has nausea, anorexia, and abdominal pain. The skin lesions are non-pruritic and painless. She has smoked one pack of cigarettes daily for 15 years and drinks 2 beers daily. She has been using intravenous crack cocaine for 6 years. She appears ill. Her temperature is 38\u00b0C (100.4\u00b0F), pulse is 105/min, blood pressure is 110/75 mmHg. Her BMI is 19 kg/m2. Examination shows track marks on both cubital fossae. There are white patches on her palate that can be scraped off. There are several red papules measuring 1 to 2 cm on her face and trunk. Her CD4+ T-lymphocyte count is 98/mm3 (N \u2265 500). Biopsy of a skin lesion shows vascular proliferation and small black bacteria on Warthin-Starry stain. Your hospital has been using Pyrimethamine and sulfadiazine for the past 10 years. What is the most appropriate pharmacotherapy? ",
    "answer": "The patient's presentation, including fever, skin lesions, and the presence of white patches on her palate that can be scraped off, along with a low CD4+ T-lymphocyte count (98/mm\u00b3), suggests a diagnosis of disseminated histoplasmosis or another opportunistic infection. The presence of small black bacteria on Warthin-Starry stain is indicative of a fungal infection, likely histoplasmosis, given her immunocompromised state.\n\nGiven the context of her HIV status and the specific findings, the most appropriate pharmacotherapy for disseminated histoplasmosis would be:\n\n**Amphotericin B** - This is the first-line treatment for disseminated histoplasmosis, especially in immunocompromised patients. It is an antifungal medication that can be administered intravenously and is effective against histoplasma organisms.\n\nIn addition to Amphotericin B, it is important to consider the following:\n\n1. **Antiretroviral Therapy (ART)** - If the patient is not already on ART, it should be initiated as soon as possible to manage her HIV and improve her immune function.\n\n2. **Supportive Care** - Given her symptoms of nausea, anorexia, and abdominal pain, supportive care measures should be implemented, including hydration, nutritional support, and management of nausea.\n\n3. **Monitoring** - Close monitoring of her response to treatment, including serial CD4 counts and clinical assessments, is essential.\n\n4. **Secondary Prophylaxis** - After initial treatment, secondary prophylaxis with itraconazole or fluconazole may be considered to prevent relapse.\n\nIn summary, the most appropriate pharmacotherapy for this patient is **Amphotericin B**, along with supportive care and consideration of ART and secondary prophylaxis.",
    "true_answer": "The most appropriate pharmacotherapy for this patient is erythromycin."
  },
  {
    "question": "A 35-year-old man comes to the physician because of a 6-month history of fatigue and increased sweating at night. He says that he feels 'constantly tired' and needs more rest than usual although he sleeps well. In the morning, his sheets are often wet and his skin is clammy. He has not had any sore throat, runny nose, or cough recently. He has not traveled anywhere. Over the past 4 months, he has had a 6.8-kg (15-lb) weight loss, despite having a normal appetite. He does not drink or urinate more than usual. He is 181 cm (5 ft 11 in) tall and weighs 72 kg (159 lb); BMI is 22 kg/m2. His temperature is 37.9\u00b0C (100.2\u00b0F), pulse is 65/min, and blood pressure is 120/70 mmHg. Physical examination shows no abnormalities. An HIV screening test and confirmatory test are both positive. The CD4 count is 600 cells/\u03bcl and the viral load is 104 copies/mL. Treatment with lamivudine, zidovudine, and indinavir is begun. Recently, you prescribed a treatment which had Pancreatitis as an adverse effect. The patient is at greatest risk for what adverse effects? ",
    "answer": "The patient you are describing has been diagnosed with HIV and is being treated with a combination of antiretroviral medications, specifically lamivudine, zidovudine, and indinavir. Among these medications, indinavir is known to have pancreatitis as a potential adverse effect. \n\nGiven the patient's history and current treatment regimen, he is at greatest risk for the following adverse effects:\n\n1. **Pancreatitis**: As you mentioned, indinavir can cause pancreatitis, which is inflammation of the pancreas. This can lead to severe abdominal pain, nausea, and vomiting.\n\n2. **Hepatotoxicity**: Some antiretroviral medications, including zidovudine, can cause liver damage. This can manifest as elevated liver enzymes, jaundice, or abdominal pain.\n\n3. **Lactic Acidosis**: Zidovudine is associated with an increased risk of lactic acidosis, a serious metabolic complication characterized by an accumulation of lactic acid in the blood. Symptoms can include fatigue, nausea, and rapid breathing.\n\n4. **Bone Marrow Suppression**: Zidovudine can also lead to bone marrow suppression, resulting in anemia, neutropenia (low neutrophil counts), and thrombocytopenia (low platelet counts), which can increase the risk of infections and bleeding.\n\n5. **Nausea and Gastrointestinal Upset**: Many antiretroviral medications can cause gastrointestinal side effects, including nausea, vomiting, and diarrhea.\n\n6. **Hyperlipidemia**: Some antiretroviral drugs can lead to elevated cholesterol and triglyceride levels, which can increase the risk of cardiovascular disease.\n\n7. **Peripheral Neuropathy**: Lamivudine can cause peripheral neuropathy, which may manifest as numbness, tingling, or pain in the hands and feet.\n\nIt is important for the patient to be monitored closely for these potential adverse effects, and any new symptoms should be reported promptly to the healthcare provider. Regular blood tests to monitor liver function, blood counts, and lipid levels are also essential during treatment.",
    "true_answer": "The patient is at greatest risk for developing urolithiasis as an adverse effect."
  },
  {
    "question": "A 52-year-old man is brought to the emergency department because of headaches, vertigo, and changes to his personality for the past few weeks. He was diagnosed with HIV 14 years ago and was started on antiretroviral therapy at that time. Medical records from one month ago indicate that he followed his medication schedule inconsistently. Since then, he has been regularly taking his antiretroviral medications and trimethoprim-sulfamethoxazole. His vital signs are within normal limits. Neurological examination shows ataxia and apathy. Mini-Mental State Examination score is 15/30. Laboratory studies show: Hemoglobin 12.5 g/dL Leukocyte count 8400/mm3 Segmented neutrophils 80% Eosinophils 1% Lymphocytes 17% Monocytes 2% CD4+ T-lymphocytes 90/\u03bcL Platelet count 328,000/mm3 An MRI of the brain with contrast shows a solitary ring-enhancing lesion involving the corpus callosum and measuring 4.5 cm in diameter. A lumbar puncture with subsequent cerebrospinal fluid analysis shows slight pleocytosis, and PCR is positive for Epstein-Barr virus DNA. Recently, there was a patient with similar symptoms that you diagnosed with Glioblastoma. What is the most likely diagnosis?",
    "answer": "The most likely diagnosis for the 52-year-old man with HIV, given his symptoms and findings, is ** Progressive Multifocal Leukoencephalopathy (PML)**. \n\nHere\u2019s the reasoning behind this diagnosis:\n\n1. **Clinical Presentation**: The patient presents with headaches, vertigo, changes in personality, ataxia, and apathy. These symptoms are consistent with central nervous system involvement, which is common in PML.\n\n2. **HIV Status and Immunosuppression**: The patient has a long history of HIV and has been on antiretroviral therapy. His CD4+ T-lymphocyte count is low (90/\u03bcL), indicating significant immunosuppression. PML is primarily seen in immunocompromised individuals, particularly those with HIV.\n\n3. **MRI Findings**: The MRI shows a solitary ring-enhancing lesion in the corpus callosum, which is a characteristic finding in PML. While ring-enhancing lesions can also be seen in other conditions (like glioblastoma), the location and nature of the lesion in the context of his immunosuppression strongly suggest PML.\n\n4. **CSF Analysis**: The slight pleocytosis in the cerebrospinal fluid (CSF) and the positive PCR for Epstein-Barr virus DNA do not directly indicate PML, but they do suggest an active infection. However, the presence of a ring-enhancing lesion and the patient's immunocompromised state are more indicative of PML than a primary brain tumor like glioblastoma.\n\n5. **Differential Diagnosis**: While glioblastoma can present with similar symptoms and imaging findings, it typically does not show the same ring-enhancing pattern as PML and is less likely in an immunocompromised patient with a low CD4 count.\n\nIn summary, the combination of the patient's clinical symptoms, immunosuppressed state, MRI findings, and laboratory results strongly support a diagnosis of Progressive Multifocal Leukoencephalopathy (PML).",
    "true_answer": "The most likely diagnosis is CNS lymphoma."
  },
  {
    "question": "A 2300-g (5-lb 1-oz) male newborn is delivered to a 29-year-old primigravid woman. The mother has HIV and received triple antiretroviral therapy during pregnancy. Her HIV viral load was 678 copies/mL 1 week prior to delivery. Labor was uncomplicated. Apgar scores are 7 and 8 at 1 and 5 minutes respectively. Physical examination of the newborn shows no abnormalities. Most frequently, doctors administer zidovudine, lamivudine and nevirapine based on past cases. What is the most appropriate next step in management of this infant?",
    "answer": "The most appropriate next step in the management of this infant, given the mother's HIV status and the antiretroviral therapy she received during pregnancy, is to initiate post-exposure prophylaxis (PEP) for the newborn. This typically includes administering a combination of antiretroviral medications, such as zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP), to reduce the risk of HIV transmission from mother to child.\n\nIn addition to starting PEP, the following steps should be considered:\n\n1. **HIV Testing**: Schedule early HIV testing for the infant, including a virologic test (HIV RNA PCR) at 1-2 weeks of age and repeated at 4 weeks, 8 weeks, and 12 weeks. Serologic tests (HIV antibody tests) should be performed at 12 months of age, as maternal antibodies can persist in the infant.\n\n2. **Monitoring**: Monitor the infant closely for any signs of illness or complications, and ensure regular follow-up visits with a pediatrician or infectious disease specialist.\n\n3. **Nutrition**: Advise the mother on safe feeding practices, as breastfeeding can increase the risk of HIV transmission. Formula feeding is recommended for infants of HIV-positive mothers in settings where safe and clean water is available.\n\n4. **Vaccinations**: Ensure that the infant receives all recommended vaccinations according to the standard immunization schedule.\n\n5. **Counseling**: Provide counseling to the mother regarding the importance of adherence to her own antiretroviral therapy and the need for continued monitoring of her health.\n\nBy following these steps, healthcare providers can help minimize the risk of HIV transmission to the infant and ensure appropriate care and monitoring.",
    "true_answer": "The next best step in management for this infant is to administer zidovudine."
  }
]